MEEX Speaker



Scientist III Drug Metabolism and Pharmacokinetics Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, Connecticut, US


Meeghan Michalewicz, M.S. is a Scientist III in the department of Drug Metabolism and Pharmacokinetics at Boehringer Ingelheim Pharmaceuticals, Inc. in Ridgefield, CT. Meeghan received her B.S. degree in Forensic Science and Chemistry from the University of New Haven. She then earned her M.S. in Pharmaceutical Sciences from the University of Connecticut. At UConn Meeghan studied with Dr. José Manautou; her thesis project involved the identification of differentially expressed genes in a model of acetaminophen autoprotection. Meeghan previously presented her thesis work at a Northeast Society of Toxicology annual meeting, and has presented posters at various scientific meetings, including the Gordon Research Conference and multiple Society of Toxicology meetings. At Boehringer Ingelheim, Meeghan is responsible for the design and validation of drug transporter assays to support development projects. Her interests include new advances in the transporter field as well as enzyme and transporter interplay. She is a member of the American Association of Pharmaceutical Scientists (AAPS), and recently presented at a TRIUMPH seminar in Cambridge, MA.